DRIVIN G ROWTH - Dr. Reddy's
DRIVIN G ROWTH - Dr. Reddy's
DRIVIN G ROWTH - Dr. Reddy's
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Table 2<br />
|<br />
Remuneration<br />
of the directors<br />
IN RS. THOUSAND<br />
NAME OF DIRECTORS SITTING FEES* COMMISSIONS** SALARIES PERQUISITES*** TOTAL<br />
<strong>Dr</strong>. K Anji Reddy NA 96,399 1,200 944 98,543<br />
G V Prasad NA 48,199 1,080 304 49,583<br />
Satish Reddy NA 48,199 1,080 278 49,557<br />
<strong>Dr</strong>. Omkar Goswami 50 1,200 NA NA 1,250<br />
P N Devarajan 55 1,200 NA NA 1,255<br />
Ravi Bhoothalingam 55 1,200 NA NA 1,255<br />
<strong>Dr</strong>. P Satyanarayana Rao 45 1,200 NA NA 1,245<br />
<strong>Dr</strong>. V Mohan 20 800 NA NA 820<br />
<strong>Dr</strong>. A Venkateswarlu 55 1,200 NA NA 1,255<br />
Prof. Krishna G. Palepu 0 0 NA NA 0<br />
Notes: *Sitting fees include fees for board as well as committee meetings. ** Commissions are variable, and based<br />
on % of net profit calculated according to Section 198 of Companies Act, 1956. ***Perquisites include house rent<br />
allowance, medical reimbursement for self and family according to the rules of the company, leave travel assistance,<br />
personal accident insurance, company vehicle for official use with driver, telephone at residence and superannuation<br />
benefits.<br />
product liability claims of a substantial nature,<br />
■ risk analysis of various products, markets and<br />
businesses,<br />
■ detailed analysis of potential acquisition<br />
targets, or possible divestments,<br />
■ details of any joint venture or collaboration<br />
agreement,<br />
■ transactions that involve substantial payment<br />
towards goodwill, brand equity or intellectual<br />
property,<br />
■ significant sale of investments, subsidiaries,<br />
assets, which are not in the normal course of<br />
business,<br />
■ any contracts in which director(s) are deemed<br />
to be interested,<br />
■ materially important show cause, demand,<br />
prosecution and penalty notices,<br />
■ fatal or serious accidents or dangerous<br />
occurrences,<br />
■ significant effluent or pollution problems,<br />
■ materially relevant default in financial<br />
obligations to and by the company or<br />
substantial non-payment for goods sold by<br />
the company,<br />
■ significant labour problems and their<br />
proposed solutions,<br />
■ significant development in the human<br />
resources and industrial relations fronts,<br />
■ quarterly details of foreign exchange exposure<br />
and the steps taken by management to limit<br />
DR. REDDY’S LABORATORIES LTD. | CORPORATE GOVERNANCE | ANNUAL REPORT 2001-2002<br />
73
Change language